Neoadjuvant use of ipilimumab in locally advanced melanoma

Lynn J. Howie, Douglas Tyler, April K S Salama

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting.

    Original languageEnglish (US)
    Pages (from-to)841-843
    Number of pages3
    JournalJournal of Surgical Oncology
    Volume112
    Issue number8
    DOIs
    StatePublished - Dec 15 2015

    Fingerprint

    Melanoma
    Extremities
    ipilimumab
    Therapeutics

    Keywords

    • immunotherapy
    • ipilimumab
    • melanoma
    • neoadjuvant

    ASJC Scopus subject areas

    • Surgery
    • Oncology

    Cite this

    Neoadjuvant use of ipilimumab in locally advanced melanoma. / Howie, Lynn J.; Tyler, Douglas; Salama, April K S.

    In: Journal of Surgical Oncology, Vol. 112, No. 8, 15.12.2015, p. 841-843.

    Research output: Contribution to journalArticle

    Howie, Lynn J. ; Tyler, Douglas ; Salama, April K S. / Neoadjuvant use of ipilimumab in locally advanced melanoma. In: Journal of Surgical Oncology. 2015 ; Vol. 112, No. 8. pp. 841-843.
    @article{2a93b93156924682b336f2005b5c80f1,
    title = "Neoadjuvant use of ipilimumab in locally advanced melanoma",
    abstract = "Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting.",
    keywords = "immunotherapy, ipilimumab, melanoma, neoadjuvant",
    author = "Howie, {Lynn J.} and Douglas Tyler and Salama, {April K S}",
    year = "2015",
    month = "12",
    day = "15",
    doi = "10.1002/jso.24079",
    language = "English (US)",
    volume = "112",
    pages = "841--843",
    journal = "Journal of Surgical Oncology",
    issn = "0022-4790",
    publisher = "Wiley-Liss Inc.",
    number = "8",

    }

    TY - JOUR

    T1 - Neoadjuvant use of ipilimumab in locally advanced melanoma

    AU - Howie, Lynn J.

    AU - Tyler, Douglas

    AU - Salama, April K S

    PY - 2015/12/15

    Y1 - 2015/12/15

    N2 - Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting.

    AB - Recent advances in immune modulating therapies show great promise for patients with advanced melanoma, however optimal strategies for achieving long-term disease control in locally advanced melanoma are unclear. We present two cases of neoadjuvant ipilimumab, one case in combination with isolated limb infusion (ILI) followed by surgical resection and one followed by surgery alone. Both patients have had durable responses. These cases highlight the ongoing need for prospective trials in the neoadjuvant setting.

    KW - immunotherapy

    KW - ipilimumab

    KW - melanoma

    KW - neoadjuvant

    UR - http://www.scopus.com/inward/record.url?scp=84954503878&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84954503878&partnerID=8YFLogxK

    U2 - 10.1002/jso.24079

    DO - 10.1002/jso.24079

    M3 - Article

    VL - 112

    SP - 841

    EP - 843

    JO - Journal of Surgical Oncology

    JF - Journal of Surgical Oncology

    SN - 0022-4790

    IS - 8

    ER -